finafloxacin hydrochlorideProduct ingredient for Finafloxacin
- Name
- finafloxacin hydrochloride
- Drug Entry
- Finafloxacin
Finafloxacin is a fluoroquinolone antibiotic indicated in the treatment of acute otitis externa (swimmer's ear) caused by the bacteria Pseudomonas aeruginosa and Staphylococcus aureus. Finafloxacin is marketed by Novartis under the brand Xtoro™, and was approved by the FDA in December 2014.
- Accession Number
- DBSALT001107
- Structure
Structure for finafloxacin hydrochloride (DBSALT001107)
- Synonyms
- finafloxacin HCl